163 related articles for article (PubMed ID: 29216279)
21. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
[TBL] [Abstract][Full Text] [Related]
22. The Risk of Colorectal Cancer After Cholecystectomy or Appendectomy: A Population-based Cohort Study in Korea.
Lee J; Choe S; Park JW; Jeong SY; Shin A
J Prev Med Public Health; 2018 Nov; 51(6):281-288. PubMed ID: 30514058
[TBL] [Abstract][Full Text] [Related]
23. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
[TBL] [Abstract][Full Text] [Related]
24. Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case-Control Study Using National Health Insurance Data.
Kwon MJ; Han KM; Kim JH; Kim JH; Kim MJ; Kim NY; Choi HG; Kang HS
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067310
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
26. Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.
Chen HY; Lin JJ; Yang B; Lin MC
Clin Rheumatol; 2020 Sep; 39(9):2773-2780. PubMed ID: 32152918
[TBL] [Abstract][Full Text] [Related]
27. Colorectal Cancer Risks According to Sex Differences in Patients With Type II Diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study.
Lee JM; Lee KM; Kim DB; Ko SH; Park YG
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00090. PubMed ID: 31651449
[TBL] [Abstract][Full Text] [Related]
28. A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.
Graham C; Orr C; Bricks CS; Hopman WM; Hammad N; Ramjeesingh R
Curr Oncol; 2016 Dec; 23(6):e583-e588. PubMed ID: 28050148
[TBL] [Abstract][Full Text] [Related]
29. Chronic proton pump inhibitor therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sedarat A; Lewis JD
Gastroenterology; 2007 Sep; 133(3):748-54. PubMed ID: 17678926
[TBL] [Abstract][Full Text] [Related]
30. The risk of colorectal cancer is associated with the frequency of meat consumption in a population-based cohort in Korea.
Kim J; Park S; Nam BH
Asian Pac J Cancer Prev; 2011; 12(9):2371-6. PubMed ID: 22296386
[TBL] [Abstract][Full Text] [Related]
31. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
[TBL] [Abstract][Full Text] [Related]
32. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
[TBL] [Abstract][Full Text] [Related]
33. Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study.
Chen CH; Lee CZ; Lin YC; Kao LT; Lin HC
J Clin Pharmacol; 2019 Mar; 59(3):350-355. PubMed ID: 30329162
[TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study.
Yee J; Han HW; Gwak HS
Br J Clin Pharmacol; 2022 Jun; 88(6):2738-2746. PubMed ID: 34970788
[TBL] [Abstract][Full Text] [Related]
35. Pernicious anemia and colorectal cancer risk - A nested case-control study.
Boursi B; Mamtani R; Haynes K; Yang YX
Dig Liver Dis; 2016 Nov; 48(11):1386-1390. PubMed ID: 27481584
[TBL] [Abstract][Full Text] [Related]
36. Association between use of proton pump inhibitors and occurrence of colon diverticulitis.
Ho BL; Hu HY; Chang SS
J Chin Med Assoc; 2016 Jan; 79(1):5-10. PubMed ID: 26404898
[TBL] [Abstract][Full Text] [Related]
37. Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study.
Dai YX; Tai YH; Chen CC; Chang YT; Chen TJ; Chen MH
J Dermatol; 2020 Oct; 47(10):1126-1130. PubMed ID: 32613686
[TBL] [Abstract][Full Text] [Related]
38. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]